Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myeloma

导出原文传递

翻译打印收藏纠错

作者： Moreau, Philippe ^[1] ; Facon, Thierry ^[2] ; Touzeau, Cyrille ^[3] ; Benboubker, Lotfi ^[4] ; Delain, Martine ^[5] ; Badamo-Dotzis, Julie ^[6] ; Phelps, Charles ; Doty, Christopher ; Smit, Hans ; Fourneau, Nele ; Forslund, Ann ; Hellemans, Peter ; Leleu, Xavier

作者单位： CHRU Bretonneau, Ctr H Kaplan, Serv Hematol, Tours, France ^[1] CHU Nantes, Hop Hotel Dieu, Serv Hematol, F-44035 Nantes 01, France ^[2] Quintiles, Div Janssen Cilag, Issy Les Moulineaux, France ^[3] Janssen Res & Dev, Raritan, NJ USA ^[4] Janssen Res & Dev, Beerse, Belgium ^[5] CHRU Lille, Hop Claude Huriez, Serv Malad Sang, F-59037 Lille, France ^[6]

关键词 Bortezomib dexamethasone histone deacetylase inhibitor multiple myeloma quisinostat

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交